Authors

Adrian Toutoungi

Partner

Read More

Josef Fuss

Partner

Read More
Authors

Adrian Toutoungi

Partner

Read More

Josef Fuss

Partner

Read More

23 June 2020

Venture-backed biotech companies – 2 of 2 Insights

Impact of COVID-19 on venture-backed biotech companies – Part 2: Investment and cash flow

  • IN-DEPTH ANALYSIS
Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Life sciences & healthcare

Biotech acquisition trend: radiopharmaceuticals

8 May 2024
Briefing

by Adrian Toutoungi

Click here to find out more
Life sciences & healthcare

Edison Open House Global Healthcare 2021 – key takeaways from our panel

4 February 2021
Quick read

by multiple authors

Click here to find out more
Life sciences & healthcare

Impact of COVID-19 on venture-backed biotech companies – Part 1: Operational issues

22 June 2020
IN-DEPTH ANALYSIS

by Adrian Toutoungi and Josef Fuss

Click here to find out more